|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Amortization of debt discount and issuance cost | |||||
| Bad debt expense | |||||
| Gain on settlement of liabilities | |||||
| Paid-in-kind interest on short-term debt | |||||
| Changes in deferred tax assets and liabilities | |||||
| Change in allowance for sales returns and volume rebate | |||||
| Change in inventory reserve | |||||
| Change in fair value of derivative liability | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| Total change in fair value of derivative liability | |||||
| Change in fair value of common warrants | |||||
| Stock compensation expense | |||||
| Depreciation and amortization | |||||
| Impairment of goodwill | |||||
| Loss on disposal of asset | |||||
| Loss on warrant issuance | |||||
| Change in right of use assets and lease liabilities | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable – trade | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| Total accounts payable and accrued expenses | |||||
| Other short-term liabilities | |||||
| Other long-term liabilities | |||||
| Deferred revenues | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Asset acquisition | |||||
| Purchases of furniture and fixtures, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from issuance of common stock and warrants, net of issuance costs | |||||
| Proceeds from issuances of short-term debt | |||||
| Proceeds from exercise of options and warrants | |||||
| Principal payments on long-term debt | |||||
| Proceeds from long term debt | |||||
| Principal payments on short-term debt | |||||
| Payments of fixed dividends to Series B Preferred stockholders | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from issuance of common stock and prefunded warrants, net of issuance costs | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from At-the-Market offering program | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign currency exchange rates | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of the year | |||||
| Cash and cash equivalents, end of the year | |||||
| Supplemental cash flow disclosures: | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Non-cash investing and financing transactions: | |||||
| Addition of operating lease liabilities | |||||
| Shares issued for asset acquisition | |||||
| Related party inventory financing | |||||
| Reclassification of warrant liabilities | |||||
Loading...